Dyadic International, a global biotechnology, signed a research , development and license agreement with a major provider of animal nutritional solutions around the world (the "Commercial Partner") to develop, manufacture and commercialise animal feed enzyme products. The identity of the Commercial Partner under the agreement with Dyadic will remain anonymous.
As part of this agreement, Dyadic has granted the Commercial Partner a worldwide license to use the developed C1 fungal strains to manufacture and sell animal feed enzyme products. Dyadic will receive an upfront access fee and be eligible to receive a commercial milestone payment as well as royalties based on the Commercial Partner's worldwide sales of products which utilise the C1 technology platform. Read more ...
This blog is written by Martin Little, The Global Miller, published and supported by the GFMT Magazine and the International Milling Directory from Perendale Publishers
No comments:
Post a Comment